Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 39 announcements

Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹2,293.50
Market cap: ₹64,728 Cr
Revenue (annual): ₹16,983 Cr
Net profit (annual): ₹1,362 Cr
P/E (TTM): 36.0×Sector 47.4×
Promoter holding: 46.65%+0.00% QoQ
FII holding: 20.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Product Launch 3 Earnings Call 3 Other Announcement 2 Business Update 2 Annual General Meeting 2 Results Update 1 Regulatory Approval 1 Legal & Regulatory 1 Financial Results 1 Employee Stock Options 1 Credit Rating 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

15 Jul 2026 15:30 IST BSE

Board Meeting Date

Glenmark Pharmaceuticals Board Meeting Date

Glenmark Pharmaceuticals scheduled a board meeting on July 31, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗